State MD
Clinical Trials in Maryland
Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.
Top Conditions in Maryland
Frequently Asked Questions — Clinical Trials in Maryland
How many clinical trials are currently recruiting in Maryland?
ClinicalMetric currently tracks 189 actively recruiting clinical trials with at least one location in Maryland. The total number of registered studies—including active but not currently enrolling trials—is 189. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Maryland?
Maryland hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Lung Cancer, Opioid Use Disorder, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Maryland serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Maryland?
To join a clinical trial in Maryland, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Maryland maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Maryland
NCT05281471 Phase 3
Recruiting
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Phy...
Condition
Platinum-resistant Ovarian Cancer
Enrollment
186 pts
Location
United States
Sponsor
Genelux Corporation
NCT05213598 N/A
Recruiting
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Sev...
Condition
Congenital Heart Disease
Enrollment
100 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT05626114 Phase 2
Recruiting
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Acti...
Condition
Geographic Atrophy
Enrollment
60 pts
Location
United States, Israel
Sponsor
Genentech, Inc.
NCT03685721 N/A
Recruiting
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Dipho...
Condition
Sickle Cell
Enrollment
800 pts
Location
United States
Sponsor
National Heart, Lung, and Bloo
NCT06976138 N/A
Recruiting
Sleep TO Prevent Post-surgical Pain
Condition
Knee Osteoarthristis
Enrollment
252 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05421858 Phase 3
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult P...
Condition
Candidemia
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Basilea Pharmaceutica
NCT07019155 N/A
Recruiting
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Pr...
Condition
Germline Mutation
Enrollment
510 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
NCT06778863 Phase 1
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R17...
Condition
Advanced Solid Tumor
Enrollment
90 pts
Location
United States
Sponsor
Clasp Therapeutics, Inc.
NCT06448754 Phase 2
Recruiting
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Condition
Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT07102394 Phase 1
Recruiting
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibr...
Condition
NF1
Enrollment
10 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05630781 N/A
Recruiting
Orexin s Role in the Neurobiology of Substance Use Disorder
Condition
Nicotine Dependence
Enrollment
140 pts
Location
United States
Sponsor
National Institute on Drug Abu
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT03339128 Phase 2
Recruiting
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bow...
Condition
Irritable Bowel Syndrome
Enrollment
95 pts
Location
United States, Bulgaria, Canada
Sponsor
AbbVie
NCT06406465 Phase 2
Recruiting
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Condition
Carcinoma, Neuroendocrine
Enrollment
60 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07534592 Phase 1
Recruiting
A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastat...
Condition
Healthy Participants
Enrollment
40 pts
Location
United States
Sponsor
AstraZeneca
NCT05675930 Phase 2
Recruiting
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Hos...
Condition
Graft-Versus-Host Disease
Enrollment
44 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06503367 N/A
Recruiting
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscul...
Condition
LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)
Enrollment
44 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT07252232 Phase 3
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Ade...
Condition
Pancreatic Cancer
Enrollment
500 pts
Location
United States, Puerto Rico, United Kingdom
Sponsor
Revolution Medicines, Inc.
NCT00040352 N/A
Recruiting
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Fami...
Condition
Melanoma
Enrollment
3,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07497399 Phase 2
Recruiting
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
120 pts
Location
United States
Sponsor
Johns Hopkins University
NCT00061828 N/A
Recruiting
A Prospective Database of Infants With Cholestasis
Condition
Biliary Atresia
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
NCT06128928 N/A
Recruiting
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Co...
Condition
COVID-19
Enrollment
900 pts
Location
United States
Sponsor
Johns Hopkins University
NCT00001467 N/A
Recruiting
Genetic Analysis of Immune Disorders
Condition
DOK 8
Enrollment
5,000 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05608421 N/A
Recruiting
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate P...
Condition
Violence, Domestic
Enrollment
100 pts
Location
United States
Sponsor
Johns Hopkins University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology